Ms Kathleen M Sherlock, LSCSW | |
750 S Range, Colby, KS 67701 | |
(785) 462-6774 | |
(785) 462-3690 |
Full Name | Ms Kathleen M Sherlock |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 750 S Range, Colby, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700938149 | NPI | - | NPPES |
66138 | Other | KS | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | LSCSW1838 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Kathleen M Sherlock, LSCSW 200 S Mission Ridge, Colby, KS 67701 Ph: (785) 460-7353 | Ms Kathleen M Sherlock, LSCSW 750 S Range, Colby, KS 67701 Ph: (785) 462-6774 |
News Archive
The South African Parliament has taken a brave and powerful step towards promoting the health of the country's citizens and reducing diet-related noncommunicable diseases (NCDs), such as diabetes, by passing a bill yesterday to implement a tax on sugar-sweetened beverages, according to Dr Rufaro Chatora, WHO's Representative to South Africa.
University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S. Department of Defense to fund two projects that aim to establish the groundwork for the nation's first whole-eye transplantation program.
In the last three decades, thousands of women with breast cancer have taken the drug tamoxifen, only to discover that the therapy doesn't work, either because their tumors do not respond to the treatment at all, or because they develop resistance to it over time. Now researchers at the University of California, San Francisco (UCSF) have discovered the molecular basis for tamoxifen resistance and found a potential way to defeat it.
A new study has found that estrogen therapy is the best treatment for menopause-related hot flashes.
Work supported by the Stand Up To Cance - Cancer Research Institute - Immunology Translational Research Dream Team, launched in 2012 to focus on how the patient's own immune system can be harnessed to treat some cancers have pioneered an approach to predict why advanced melanoma patients respond to a new life-saving melanoma drug.
› Verified 9 days ago